| Filed On | Filing |
|---|---|
| 04 Nov 2025 |
8-K/A: Results of Operations and Financial Condition
SALT LAKE CITY, November 3, 2025 – Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its third quarter ended September 30, 2025 and reaffirmed its... |
| 07 Feb 2020 | 8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 15 Oct 2018 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 14 Nov 2016 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 09 May 2014 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 06 Feb 2007 | 8-K/A: Results of Operations and Financial Condition; Other Events |
Loading...
